8 October 2020 - The company is also willing to license the technology behind its experimental coronavirus vaccine.
Moderna said it wouldn’t enforce patents related to its experimental COVID-19 vaccine while the pandemic continues and is willing to license the patents to others after the pandemic.
The Cambridge, MA company has at least seven U.S. patents related to its vaccine, including one for the invention of a vaccine using a gene-based technology to protect against a family of coronaviruses. The family of viruses includes the one that causes COVID-19.